New Trials
Latest round
- Series A
Last raised
- Feb 2025
Total raised
- Undisclosed
Investors
- 5
About New Trials
Founded in 2020 and based in Hangzhou, China, New Trials is a medical technology company that provides digital platforms and services in the field of clinical trials. Jiefei Jin, the founder, and CEO of the company, used to work for Pfizer and medical big data companies. As of 2022, the company has nearly 70 employees. The company is engaged in providing digital platforms and services in the field of clinical trials, aiming to provide products and services for pharmaceutical enterprises, CRO companies, SMO companies, and hospitals in the clinical trials industry through big data, artificial intelligence, and other technology. The main products include CTMS (Clinical Trial Management System), GCP Pharmacy and CTRM (Clinical Trial Monitoring System), etc. The company's main source comes from charging clinical trial sponsors on a SaaS subscription model.
Who invested in New Trials
5 investors across 2 rounds
See all investors in New Trials
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about New Trials
Who invested in New Trials?
New Trials has 5 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has New Trials raised?
New Trials has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did New Trials last raise money?
New Trials's most recent round on record is a Series A, in Feb 2025.
What does New Trials do?
Founded in 2020 and based in Hangzhou, China, New Trials is a medical technology company that provides digital platforms and services in the field of clinical trials.
Where is New Trials headquartered?
New Trials is headquartered in Hangzhou, China.
Which VCs invest in companies like New Trials?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back healthcare it companies at New Trials's stage. Their profiles are linked below.
VCs backing healthcare it startups at Series A
Raising like New Trials? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.